Molecular Diagnostics
News on lab-developed tests and emerging diagnostic technologies.
EntroGen Colorectal Cancer RAS Mutation Detection Test Nabs CMS Coverage
The real-time PCR-based companion diagnostic test identifies patients eligible for treatment with Amgen's Vectibix (panitumumab).
AccuStem Sciences Partners With EmeritusDx on Molecular Lung Cancer Screening Test
The companies previously agreed to jointly develop AccuStem's recurrence predictor assay for patients with breast cancer.
Craif Raises $22M in Series C Round to Expand US, Japan Operations
The Nagoya University spinout will open an office in San Diego and is working toward FDA approval of its miSignal early cancer detection test.
McKesson Looks to Improve Precision Oncology Access in Community Practice With New Consortium
Premium
Through its Precision Care Companion, McKesson wants to help oncologists bring personalized medicine to their patients.
Interpace Diagnostics to Cease PancraGen Testing After Losing CMS Reimbursement
The fate of its pancreatic cancer test had been in limbo for years, but with a newly active LCD from Medicare contractor Novitas, the firm has had to close the book on the assay.